Phibro Animal Health (PAHC)
(Delayed Data from NSDQ)
$26.11 USD
-0.39 (-1.47%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $26.13 +0.02 (0.08%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth C Momentum A VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
PAHC 26.11 -0.39(-1.47%)
Will PAHC be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for PAHC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PAHC
3 Reasons Growth Investors Will Love Phibro (PAHC)
ResMed Inc. (RMD) Hit a 52 Week High, Can the Run Continue?
PAHC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Best Growth Stocks to Buy for July 23rd
Best Value Stocks to Buy for July 23rd
Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term
Other News for PAHC
Phibro Animal Health Corp Declares Quarterly Cash Dividend | PAHC stock news
Phibro Animal declares $0.12 dividend
Phibro Animal Health Corporation Declares Quarterly Dividend | PAHC Stock News
Zoetis: Poised For Growth Yet Priced For Decline (Rating Upgrade To Strong Buy)
Phibro Animal Health (PAHC) Rises on J.P. Morgan Upgrade